Trial intelligence / Profile preview

TMP-SMX vs Vancomycin for MRSA Osteomyelitis

NCT00324922Phase 3Completed

Sponsor
University of Washington
Start
May 2006
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of trimethoprim + sulfamethoxazole in osteomyelitis (OM), sponsored by University of Washington. Started May 2006; status: completed.

02

Drugs

trimethoprim + sulfamethoxazole
03

Conditions

osteomyelitis (OM)

Beyond the preview

Go deeper on NCT00324922.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00324922.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call